| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abiraterone acetate for patients with metastatic castration-resistant prostate cancer progressing after chemotherapy: final analysis of a multicentre, open-label, early-access protocol trial
|
Sternberg, Cora N
|
|
2014
|
15 |
11 |
p. 1263-1268
6 p.
|
artikel
|
| 2 |
Adenoma removal and colorectal cancer mortality
|
Burki, Talha Khan
|
|
2014
|
15 |
11 |
p. e479-
1 p.
|
artikel
|
| 3 |
Adjuvant chemotherapy for patients with rectal cancer?
|
Breugom, Anne J
|
|
2014
|
15 |
11 |
p. 1185-1186
2 p.
|
artikel
|
| 4 |
ASCT and high-dose melphalan in multiple myeloma
|
Sharma, Sharan Prakash
|
|
2014
|
15 |
11 |
p. e481-
1 p.
|
artikel
|
| 5 |
Bald Cartoons
|
Bates, James
|
|
2014
|
15 |
11 |
p. 1192-
1 p.
|
artikel
|
| 6 |
BCR-ABL1:ABL predicts outcomes in children with CML
|
Bagcchi, Sanjeet
|
|
2014
|
15 |
11 |
p. e478-
1 p.
|
artikel
|
| 7 |
Be a man—and apologise
|
Morgan, Jules
|
|
2014
|
15 |
11 |
p. 1193-1194
2 p.
|
artikel
|
| 8 |
Bevacizumab alone or in combination with chemotherapy in glioblastomas?
|
Raza, Shahzad
|
|
2014
|
15 |
11 |
p. e472-e473
nvt p.
|
artikel
|
| 9 |
Bevacizumab alone or in combination with chemotherapy in glioblastomas?–Authors' reply
|
van den Bent, Martin J
|
|
2014
|
15 |
11 |
p. e473-e474
nvt p.
|
artikel
|
| 10 |
Bevacizumab beyond progression in breast cancer
|
Dirix, Luc Y
|
|
2014
|
15 |
11 |
p. 1190-1191
2 p.
|
artikel
|
| 11 |
Bevacizumab plus chemotherapy versus chemotherapy alone as second-line treatment for patients with HER2-negative locally recurrent or metastatic breast cancer after first-line treatment with bevacizumab plus chemotherapy (TANIA): an open-label, randomised phase 3 trial
|
von Minckwitz, Gunter
|
|
2014
|
15 |
11 |
p. 1269-1278
10 p.
|
artikel
|
| 12 |
Biomarker predicts treatment resistance in prostate cancer
|
Wilkinson, Emma
|
|
2014
|
15 |
11 |
p. e483-
1 p.
|
artikel
|
| 13 |
Bivalent HPV vaccination effective for adult women
|
Cagney, Hannah
|
|
2014
|
15 |
11 |
p. e478-
1 p.
|
artikel
|
| 14 |
Cancer-related inflammation and treatment effectiveness
|
Diakos, Connie I
|
|
2014
|
15 |
11 |
p. e493-e503
nvt p.
|
artikel
|
| 15 |
Can we have a better death?
|
Morgan, Jules
|
|
2014
|
15 |
11 |
p. 1192-1193
2 p.
|
artikel
|
| 16 |
Cervical screening rates lower in HPV-vaccinated women
|
Kirby, Tony
|
|
2014
|
15 |
11 |
p. e479-
1 p.
|
artikel
|
| 17 |
Changes and restrictions for nicotine use
|
Tanday, Sanjay
|
|
2014
|
15 |
11 |
p. e477-
1 p.
|
artikel
|
| 18 |
Combination cediranib and olaparib versus olaparib alone for women with recurrent platinum-sensitive ovarian cancer: a randomised phase 2 study
|
Liu, Joyce F
|
|
2014
|
15 |
11 |
p. 1207-1214
8 p.
|
artikel
|
| 19 |
Combining targeted therapies in ovarian cancer
|
Scambia, Giovanni
|
|
2014
|
15 |
11 |
p. 1179-1181
3 p.
|
artikel
|
| 20 |
Correction to Lancet Oncol 2014; 15: 1039
|
|
|
2014
|
15 |
11 |
p. e475-
1 p.
|
artikel
|
| 21 |
Correction to Lancet Oncol 2014; 15: 1047
|
|
|
2014
|
15 |
11 |
p. e475-
1 p.
|
artikel
|
| 22 |
Correction to Lancet Oncol 2014; 15: 1047–48
|
|
|
2014
|
15 |
11 |
p. e475-
1 p.
|
artikel
|
| 23 |
Correction to Lancet Oncol 2014; 15: 1239
|
|
|
2014
|
15 |
11 |
p. e475-
1 p.
|
artikel
|
| 24 |
Correction to Lancet Oncol 2014; 15: 1147–56
|
|
|
2014
|
15 |
11 |
p. e475-
1 p.
|
artikel
|
| 25 |
Correction to Lancet Oncol 2014; 15: 1109–18
|
|
|
2014
|
15 |
11 |
p. e475-
1 p.
|
artikel
|
| 26 |
Cumulative alkylating agent exposure and semen parameters in adult survivors of childhood cancer: a report from the St Jude Lifetime Cohort Study
|
Green, Daniel M
|
|
2014
|
15 |
11 |
p. 1215-1223
9 p.
|
artikel
|
| 27 |
Dignified death from a different perspective
|
Yaqub, Farhat
|
|
2014
|
15 |
11 |
p. e482-
1 p.
|
artikel
|
| 28 |
Drug interactions between tyrosine-kinase inhibitors and acid suppressive agents: more than meets the eye
|
Yu, Guo
|
|
2014
|
15 |
11 |
p. e469-e470
nvt p.
|
artikel
|
| 29 |
Drug interactions between tyrosine-kinase inhibitors and acid suppressive agents: more than meets the eye–Authors' reply
|
van Leeuwen, Roelof W F
|
|
2014
|
15 |
11 |
p. e470-e471
nvt p.
|
artikel
|
| 30 |
Emotion-based medicine or evidence-based medicine?
|
The Lancet Oncology,
|
|
2014
|
15 |
11 |
p. 1177-
1 p.
|
artikel
|
| 31 |
Epidemiological differences in haematological malignancies between Europe and China
|
Chen, Xin-Chuan
|
|
2014
|
15 |
11 |
p. e471-e472
nvt p.
|
artikel
|
| 32 |
Erlotinib alone or with bevacizumab as first-line therapy in patients with advanced non-squamous non-small-cell lung cancer harbouring EGFR mutations (JO25567): an open-label, randomised, multicentre, phase 2 study
|
Seto, Takashi
|
|
2014
|
15 |
11 |
p. 1236-1244
9 p.
|
artikel
|
| 33 |
Human T-cell leukaemia virus type I and adult T-cell leukaemia-lymphoma
|
Ishitsuka, Kenji
|
|
2014
|
15 |
11 |
p. e517-e526
nvt p.
|
artikel
|
| 34 |
Hypoxia-activated TH-302 for advanced soft-tissue sarcoma
|
Rahman, Ahmadur
|
|
2014
|
15 |
11 |
p. e480-
1 p.
|
artikel
|
| 35 |
Increases in bilateral mastectomy for breast cancer
|
Burki, Talha Khan
|
|
2014
|
15 |
11 |
p. e480-
1 p.
|
artikel
|
| 36 |
Knowledge, attitudes, and behaviours towards cancer screening in indigenous populations: a systematic review
|
Kolahdooz, Fariba
|
|
2014
|
15 |
11 |
p. e504-e516
nvt p.
|
artikel
|
| 37 |
Laws on medical cannabis lower opioid overdose mortality
|
Bagcchi, Sanjeet
|
|
2014
|
15 |
11 |
p. e477-
1 p.
|
artikel
|
| 38 |
Lenalidomide in combination with R-CHOP in lymphoma
|
Bagcchi, Sanjeet
|
|
2014
|
15 |
11 |
p. e476-
1 p.
|
artikel
|
| 39 |
Lenalidomide in transplant-ineligible myeloma
|
Bagcchi, Sanjeet
|
|
2014
|
15 |
11 |
p. e481-
1 p.
|
artikel
|
| 40 |
Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial
|
Hong, Yong Sang
|
|
2014
|
15 |
11 |
p. 1245-1253
9 p.
|
artikel
|
| 41 |
Panobinostat for the treatment of multiple myeloma
|
Rajkumar, S Vincent
|
|
2014
|
15 |
11 |
p. 1178-1179
2 p.
|
artikel
|
| 42 |
Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: a multicentre, randomised, double-blind phase 3 trial
|
San-Miguel, Jesús F
|
|
2014
|
15 |
11 |
p. 1195-1206
12 p.
|
artikel
|
| 43 |
Patient priority in the era of patent expiries
|
Horning, Sandra
|
|
2014
|
15 |
11 |
p. e474-
1 p.
|
artikel
|
| 44 |
Pleuropulmonary blastoma early detection improves survival
|
Bagcchi, Sanjeet
|
|
2014
|
15 |
11 |
p. e483-
1 p.
|
artikel
|
| 45 |
Prevention and early detection of prostate cancer
|
Cuzick, Jack
|
|
2014
|
15 |
11 |
p. e484-e492
nvt p.
|
artikel
|
| 46 |
Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial
|
Wilke, Hansjochen
|
|
2014
|
15 |
11 |
p. 1224-1235
12 p.
|
artikel
|
| 47 |
Ramucirumab: second-line therapy for gastric cancer
|
Sasako, Mitsuru
|
|
2014
|
15 |
11 |
p. 1182-1184
3 p.
|
artikel
|
| 48 |
Real-world experience with abiraterone
|
Dahut, William L
|
|
2014
|
15 |
11 |
p. 1188-1190
3 p.
|
artikel
|
| 49 |
Risk of infertility in male survivors of childhood cancer
|
Brannigan, Robert E
|
|
2014
|
15 |
11 |
p. 1181-1182
2 p.
|
artikel
|
| 50 |
Rituximab for low-grade follicular lymphoma?
|
Sharma, Sharan
|
|
2014
|
15 |
11 |
p. e476-
1 p.
|
artikel
|
| 51 |
Six versus fewer planned cycles of first-line platinum-based chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual patient data
|
Rossi, Antonio
|
|
2014
|
15 |
11 |
p. 1254-1262
9 p.
|
artikel
|
| 52 |
The comedy brain cancer manual
|
Hill, Emma
|
|
2014
|
15 |
11 |
p. 1194-
1 p.
|
artikel
|
| 53 |
The optimum duration of front-line chemotherapy
|
Kotsakis, Athanasios
|
|
2014
|
15 |
11 |
p. 1187-1188
2 p.
|
artikel
|
| 54 |
Thoracic radiotherapy in small-cell lung cancer
|
Yaqub, Farhat
|
|
2014
|
15 |
11 |
p. e482-
1 p.
|
artikel
|
| 55 |
What new therapeutic targets exist for EGFR-mutant NSCLC?
|
Rosell, Rafael
|
|
2014
|
15 |
11 |
p. 1184-1185
2 p.
|
artikel
|
Tijdschrift beschrijving